InvestorsHub Logo
Followers 44
Posts 5554
Boards Moderated 0
Alias Born 11/15/2013

Re: steelyeye post# 383338

Wednesday, 11/10/2021 8:08:32 PM

Wednesday, November 10, 2021 8:08:32 PM

Post# of 403648
Great post going into data release. Where's there's smoke there's fire right.

The science and number of different indications Brilacidin might address continues to grow each month... lately almost week by week. The number of institutions studying it has also increased.
The number of supercomputers that agree has also increased.

Add to this Brilacidin's safety and indications of efficacy in previous clinical PH II trials, and there's no way pharma let's this one get away... with or without US government interest... With or without US military interest... With or without international governments who will also have interest if this upcoming trial data meets endpoints.

--Compassionate use has been approved for critical hospitalized Covid cases, when the IPIX PH II trial is only for moderate to severe Covid?


Freedom is not free.